Strategy question

You're the PM at a pharmaceutical company. How would you go about launching a new sleeping pill?

Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.

What this question tests

Tests strategic thinking under heavy regulatory constraints, a domain most PM interview questions don't cover.

Clarify regulatory context first: this launch requires FDA approval (prescription or OTC) and clinical trial data before any go-to-market planning.
Define the target user and channel: physician-prescribed versus OTC, since that determines whether the buyer is a doctor, pharmacist, or consumer directly.
Plan a phased launch: limited release with physician education and post-market surveillance for side effects before broad consumer marketing.
Address safety and trust: clear labeling, dosage guidance, and a pharmacovigilance process for adverse event reporting.
Define success metrics appropriate to healthcare: adherence rate, prescriber adoption, and adverse event rate, not just sales volume.

Leads with the regulatory reality (FDA approval, trials) that any real pharma PM would have to plan around first.
Distinguishes prescription-channel go-to-market from consumer-channel go-to-market, since the launch playbook differs completely.
Prioritizes safety metrics (adverse events, adherence) alongside commercial metrics, reflecting the actual priorities in this industry.
Proposes a phased, monitored rollout rather than a broad simultaneous launch, appropriate for a risk-sensitive product.

Treating this like a typical consumer product launch and skipping regulatory and safety considerations entirely.
Ignoring who the actual buyer is (physician versus consumer) and proposing a generic consumer marketing plan.

How would you handle a serious adverse event reported after launch?
How would your strategy differ for an OTC sleep aid versus a prescription sleeping pill?